Home β€Ί Stock analysis β€Ί IMCC

IM Cannabis (IMCC) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

IMCC dips 1.5% to $1.33, a 52-week low, 15 down days in a row. Closed at $1.33, -1.48% vs the prior close of $1.35. Day range $1.25–$1.38, opened at $1.31.

Last close$1.33-1.48%
Day range1.25–1.38
Open1.31
Volume46.90K
52-week range1.20–77.10
Avg volume (20d)8.51M

IMCC daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” IMCC dips 1.5% to $1.33, a 52-week low, 15 down days in a row
Oct 14, 2026 β€” IMCC dips 0.7% to $1.35, a 52-week low, 14 down days in a row
Oct 13, 2026 β€” IMCC slides 6.8% to $1.36, a 52-week low, 13 down days in a row
Oct 12, 2026 β€” IMCC slides 7.6% to $1.46, a 52-week low, 12 down days in a row
Oct 9, 2026 β€” IMCC slides 8.1% to $1.58, a 52-week low, 11 down days in a row
Oct 8, 2026 β€” IMCC slides 9.5% to $1.72, 10 down days in a row
Oct 7, 2026 β€” IMCC dips 2.1% to $1.90, 9 down days in a row
Oct 6, 2026 β€” IMCC ends flat (+0.0%) to $1.94, 8 down days in a row
Oct 5, 2026 β€” IMCC slides 4.9% to $1.94, 7 down days in a row
Oct 2, 2026 β€” IMCC slides 6.0% to $2.04, 6 down days in a row

IMCC latest news & SEC filings

Every SEC filing by or about IMCC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 8, 2026 Β· Form F-3 β€” F-3 filing

F-3 filing

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001178913-26-004744

Oct 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004699

Sep 30, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001213900-26-105248

Sep 30, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001213900-26-105246

Sep 30, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001213900-26-105245

Sep 28, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004635

Sep 25, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004610

Sep 24, 2026 Β· Form 424B5 β€” Prospectus supplement

Prospectus supplement β€” the company is selling securities off a shelf registration

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001178913-26-004583

Sep 24, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004580

Sep 23, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004574

Sep 23, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004563

Sep 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004396

Aug 27, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004289

Aug 18, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004186

Aug 17, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001178913-26-004168

Things to know before you trade IMCC

IMCC market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20261.311.381.251.3346.90K
Oct 14, 20261.321.431.201.3577.30K
Oct 13, 20261.421.491.321.3657.70K
Oct 12, 20261.551.591.401.46101.70K
Oct 9, 20261.731.781.551.58147.70K
Oct 8, 20261.871.901.671.72167.60K
Oct 7, 20261.901.941.831.90111.00K
Oct 6, 20261.922.021.851.94129.00K
Oct 5, 20262.012.011.851.94108.30K
Oct 2, 20262.102.191.952.04166.80K
Oct 1, 20262.422.432.122.17203.50K
Sep 30, 20262.472.482.212.25418.80K
Sep 29, 20262.532.772.442.451.75M
Sep 28, 20262.902.932.462.48319.00K
Sep 25, 20263.113.112.832.84608.10K
Sep 24, 20262.953.242.913.183.95M
Sep 23, 20263.183.442.612.9129.56M
Sep 22, 20264.505.703.564.1425.80M
Sep 21, 20263.183.382.833.091.47M
Sep 18, 20263.248.652.974.23104.98M

About IM Cannabis

IM Cannabis (IMCC) is listed on the Nasdaq and classified by the SEC under β€œMedicinal Chemicals & Botanical Products”. Its business address is in CENTRAL DISTRICT, Israel. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1792030.

IMCC board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

IMCC financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

IMCC earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Medicinal Chemicals & Botanical Products

Definium Therapeutics (DFTX)Regencell Bioscience (RGC)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)Aurora Cannabis (ACB)Glass House Brands (GLAS)Usana Health Sciences (USNA)Cronos (CRON)Canopy Growth (CGC)Sndl (SNDL)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on IMCC

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.